Eplerenone

Eplerenone, sold as Inspra, is an aldosterone antagonist, a medicine taken by mouth. The US label read, for Inspra tablets, lists two uses in adults: improving survival in stable people who have symptomatic heart failure with reduced ejection fraction (40% or less) after a heart attack, and the treatment of high blood pressure to lower it.

Also called Inspra

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 298869; UNII 6995V82D0B. MeSH descriptor D000077545 is Eplerenone. Class: Aldosterone Antagonist (FDA established pharmacologic class, RxClass). The label read is the Viatris Specialty LLC label for Inspra tablets, application NDA021437, effective 2025-06-23 in openFDA. Generic eplerenone labels were not read. This page records label indications, the mechanism sentence and the class only: no trial result and no dose is given.

About this drug

Level
Substance
Mechanism
The label says eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone.

Claims and evidence

Context Adults with heart failure with reduced ejection fraction after a heart attack, and adults with hypertension, as described in the US label of Inspra tablets

Recipient
Adult
Population
Stable adult patients with symptomatic heart failure with reduced ejection fraction (40% or less) after an acute myocardial infarction, and adults with hypertension, as the indications section of the label states.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Adults, as the label states
Follow-up
Not applicable (label statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
Included
  • Stable adult patients with symptomatic heart failure with reduced ejection fraction (40% or less) after an acute myocardial infarction
  • Adults with hypertension
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of Inspra (eplerenone tablets, Viatris Specialty LLC, application NDA021437; the version dated 2025-06-23 in openFDA) describes eplerenone as an aldosterone antagonist. It lists improving survival of stable adult patients with symptomatic heart failure with reduced ejection fraction (40% or less) after an acute myocardial infarction, and the treatment of hypertension in adults, to lower blood pressure.

    Applies to Adult Adults with heart failure with reduced ejection fraction after a heart attack, and adults with hypertension, as described in the US label of Inspra tablets

    Certainty method
    Not assessed
    Limitations
    This claim records what one US label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Contraindications, warnings (including raised potassium), interactions and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (4)
    1. Supports openFDA drug label record for Inspra (eplerenone tablets), Viatris Specialty LLC label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 1a52bedc-8e2c-4116-a296-a87770676b4a (manufacturer Viatris Specialty LLC, application NDA021437), returned on 2026-11-18. The label text is dated 2025-06-23 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1 INDICATIONS AND USAGE
      How it applies
      Label passage quoted in the research quote table (LB-04).
      Retrieved
      Source effective date
      2025-06-23
      Source state
      Current
      Version fingerprint
      5faf76d843730007ed843afc66f467edf02eeccc748524c7f0b7abcfb7138e90
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Supports openFDA drug label record for Inspra (eplerenone tablets), Viatris Specialty LLC label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 1a52bedc-8e2c-4116-a296-a87770676b4a (manufacturer Viatris Specialty LLC, application NDA021437), returned on 2026-11-18. The label text is dated 2025-06-23 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.1 Heart Failure Post-Myocardial Infarction
      How it applies
      Label passage quoted in the research quote table (LB-05, LB-06).
      Retrieved
      Source effective date
      2025-06-23
      Source state
      Current
      Version fingerprint
      5faf76d843730007ed843afc66f467edf02eeccc748524c7f0b7abcfb7138e90
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    3. Supports openFDA drug label record for Inspra (eplerenone tablets), Viatris Specialty LLC label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 1a52bedc-8e2c-4116-a296-a87770676b4a (manufacturer Viatris Specialty LLC, application NDA021437), returned on 2026-11-18. The label text is dated 2025-06-23 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0], 1.2 Hypertension
      How it applies
      Label passage quoted in the research quote table (LB-07).
      Retrieved
      Source effective date
      2025-06-23
      Source state
      Current
      Version fingerprint
      5faf76d843730007ed843afc66f467edf02eeccc748524c7f0b7abcfb7138e90
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    4. Background openFDA drug label record for Inspra (eplerenone tablets), Viatris Specialty LLC label: indications, mechanism, class

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 1a52bedc-8e2c-4116-a296-a87770676b4a (manufacturer Viatris Specialty LLC, application NDA021437), returned on 2026-11-18. The label text is dated 2025-06-23 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20250623.
      Retrieved
      Source effective date
      2025-06-23
      Source state
      Current
      Version fingerprint
      5faf76d843730007ed843afc66f467edf02eeccc748524c7f0b7abcfb7138e90
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Record details

Record id
cardio:eplerenone
Content hash
4612b467615436888490472bfc6632488a260a40e454e5ad3a1a476556a66950